Adagene $161 million IPO
We advised Adagene on its IPO and Nasdaq listing
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Cornell Capital acquires trustaff and CardioSolution in combination with Stella
We are advising Cornell Capital on the acquisition
Atento $500 million senior notes offering and tender offer
We advised the initial purchasers and dealer managers in connection with a Rule 144A / Regulation S offering and tender offer
Allegro MicroSystems $530.2 million secondary offering
We advised the underwriters on the equity offering
Central American Bank for Economic Integration $500 million social notes
We advised the initial purchasers on the senior, unsecured fixed-rate notes offering
Bolt Biotherapeutics $230 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Chesapeake Energy $1 billion notes offering
We advised the initial purchasers on the bond offering for Chesapeake’s emergence from bankruptcy
Immunocore $297 million IPO
We advised the joint book-running managers and underwriters on the IPO and Nasdaq listing
Janus Henderson Group $891.7 million secondary offering
We advised the underwriter on the equity offering
Sable Permian Resources emerges from chapter 11 bankruptcy
We advised an ad hoc group of secured noteholders in connection with Sable’s chapter 11 restructuring